Therapeutic effects of milnacipran (serotonin noradrenalin reuptake inhibitor) on depression following mild and moderate traumatic brain injury

Journal of Nippon Medical School

Volumn 70, Issue 4, 2003, Pages 313-320

  Kanetani, Kouichi ^a   Kimura, Mahito ^b   Endo, Shunkichi ^b  

^a Matsue Hospital   (Japan)

^b NONE

Author keywords

Antidepressant agents; Depression; Mild and moderate TBI; Milnacipran

Indexed keywords

MILNACIPRAN; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HAMILTON SCALE; HUMAN; MALE; MAXIMUM PERMISSIBLE DOSE; MINI MENTAL STATE EXAMINATION; MOOD DISORDER; NAUSEA; OPEN STUDY; REMISSION; SCORING SYSTEM; URINARY DYSFUNCTION;

EID: 0041317358     PISSN: 13454676     EISSN: None     Source Type: Journal    
DOI: 10.1272/jnms.70.313     Document Type: Article

References (47)

1. Rosenthal M, Christensen BK, Ross TP: Depression following traumatic brain injury. Arch Phys Rehabil 1998; 79: 90-103.
2. Ownsworth TL, Oei TP: Depression after traumatic brain injury: conceptualization and treatment considerations. Brain Inj 1998; 12: 735-754.
3. Newburn G: Psychiatric disorders associated with traumatic brain injury. CNS Drugs 1998; 9: 441-456.
4. Hurley RA, Taber KH: Emotional disturbances following traumatic brain injury. Curr Treat Options Neurol 2002; 4: 59-75.
5. Kreutzer JS, Seel RT, Gourley E: The prevalence and symptom rates of depression after traumatic brain injury: a comprehensive examination. Brain Injury 2001; 15: 563-576.
6. Deb S, Lyons I, Koutzoukis C, Ali I, McCarthy G: Rate of psychiatric illness 1 year after traumatic brain injury. Am J Psychiatry 1999; 156: 374-378.
7. Busch CR, Alpern HP: Depression after mild traumatic brain injury: a review of current research. Neuropsychol Rev 1998; 8 (2): 95-108.
8. Rao V, Lyketsos C: Neuropsychiatric sequelae of traumatic brain injury. Psychosomatics 2000; 41: 95103.
9. Wroblewski BA, Joseph AB, Cornblatt RR: Antidepressant Pharmacotherapy and the treatment of depression in patients with severe traumatic brain injury: a controlled, prospective study. J Clin Psychiatry 1996; 57: 582-587.
10. Muller U, Murai T, Bauer-Wittmund T, Cramon DYV: Paroxetine versus citalopram treatment of pathological crying after brain injury. Brain Inj 1999; 13: 805-811.
11. Newburn G, Edwards R, Thomas H, Coolier J, Fox K, Collins C: Moclobemide in the treatment of major depressive disorder (DSM-3) following traumatic brain injury. Brain Inj 1999; 13: 637-642.
12. Perino C, Rago R, Cicolin A, Torta R, Monaco F: Mood and behavioral disorders following traumatic brain injury. Brain Inj 2001; 15: 139-148.
13. McCleary C, Satz P, Forney D, Light R, Zaucha K, Asarnow R, Namerow N: Depression after traumatic brain injury as a function of Glasgow outcome score. J Clin Exp Neuropsychol 1998; 20: 270-279.
14. Satz P, Forney DL, Zaucha K, Asarnow RR, Light R, McCleary C, Levin H, Kelly D, Bergsneider M, Hovda D, Martin N, Namerow N, Becker D: Depression, cognition, and functional correlates of recovery outcome after traumatic brain injury. Brain Inj 1998; 12: 537-553.
15. Wilson JTL, Pettigrew LEL, Teasdale GM: Emotional and cognitive consequences of head injury in relation to the Glasgow outcome scale. J Neurol Neurosurg Psychiatry 2000; 69: 204-209.
16. Hall KM, Bushnik T, Lakisic-Kazazic B, Wright J, Cantagallo A: Assessing traumatic brain injury outcome measures for long-term follow-up of community-based individuals. Arch Phys Med Rehabil 2001; 82: 367-374.
17. Powell J, Heslin J, Greenwood R: Community based rehabilitation after severe traumatic brain injury: a randomized controlled trial. J Neurol Neurosurg Psychiatry 2002; 72: 193-202.
18. Geurts ACH, Ribbers GM, Knoop JA, Limbeek JV: Identification of static and dynamic postural instability following traumatic brain injury. Arch Phys Med Rehabil 1996; 77: 639-644.
19. Gomez-Hernandez R, Max JE, Kosier T, Paradiso S, Robinson RG: Social impairment and depression after traumatic brain injury. Arch Phys Med Rehabil 1997; 78: 1321-1326.
20. Max JE, Koele SL, Smith Jr WL, Sato Y, Lindgren SD, Robin DA, Arndt S: Psychiatric disorders in children and adolescents after severe traumatic brain injury: a controlled study. J Am Acad Child Adolesc Psychiatry 1998; 37 (8): 832-840.
21. Max JE, Arndt S, Castillo CS, Bokura H, Robin DA, Lindgren SD, Smith Jr WL, Sato Y, Mattheis PJ: Attention-deficit hyperactivity symptomatology after traumatic brain injury: a prospective study. J Am Acad Child Adolesc Psychiatry 1998; 37(8): 841-847.
22. Kersel DA, Marsh NV, Havill JH, Sleigh JW: Psychosocial functioning during the year following severe traumatic brain injury. Brain Inj 2001; 15: 683-696.
23. Levin HS, Goldstein FC, MacKenzie EJ: Depression as a secondary condition following mild and moderate traumatic brain injury. Semin Clin Neuropsychiatry 1997; 2 (3): 207-215.
24. Fann JR, Uomoto JM, Katon WJ: Sertraline in the treatment of major depression following mild traumatic brain injury. J Neuropsychiatry Clin Neurosci 2000; 12: 226-232.
25. Sheehan DV, Lecrubier Y, Sheehan KH: The Mini-international neuropsychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 Suppl 20: 22-33: quiz 34-57.
26. American psychiatric association, diagnostic and statistical manual of mental disorders: DSM-IV (4 th Ed). Washington DC: American Psychiatric Press Inc., 1994.
27. Hamilton MA: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
28. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975; 12: 189-198.
29. Adams JH, Graham DI, Murray LS: Diffuse axonal injury due to nonmissile head injury in humans: an analysis of 45 cases. Ann Neurol 1982; 12: 557-563.
30. Adams JH, Graham DI, Gennarelli TA: Contemporary neuropathological considerations regarding brain damage in head injury, In: Becker DP, povlishock JT (eds). Central Nervous System Trauma Status Report, Bethesda, MD: National Institute of Neurological and communicative Disorders and Stroke, National Institute of Health. 1985, pp 65-77.
31. Gennarelli TA, Thibault LE, Adams JH: Diffuse axonal injury and traumatic coma in the primate. Ann Neurol 1982; 12: 564-574.
32. Gennarelli TA: Emergency department management of head injuries. Emerg Med Clin North Am 1984; 2: 749-760.
33. rd Ed, Williams and Wilkins, Baltimore, 1993.
34. Jorge RE, Robinson RG, Starkstein SE, Arndt SV: Depression and anxiety following traumatic brain injury. J Neuropsychiatry Clin Neurosci 1993; 5: 369-374.
35. Fann JR, Uomoto JM, Katon WJ: Congnitive improvement with treatment of depression following mild traumatic brain injury. Psychosomatics 2001; 42: 48-54.
36. Cicerone KD, Kalmar K: Does premorbid depression influence post-concussive symptoms and neuropsychological functioning? Brain Inj 1997; 11: 643-648.
37. Gentilini M, Nichelli P, Schoenhuber R, Bortolotti P, Tonelli L, Falasca A, Merli GA: Neuropsychological evaluation of mild head injury. J Neurol Neurosurg Psychiatry 1985; 48: 137-140.
38. Karzmark P, Hall K, Englander J: Late-onset post-concussion symptoms after mild brain injury: The role of premorbid, injury-related, environmental, and personality factors. Brain Inj 1995; 9: 21-26.
39. Mooney G, Speed J: The association between mild traumatic brain injury and psychiatric conditions. Brain Inj 2001; 15: 865-877.
40. Puech A, Montgomery SA, Prost JF, Solles A, Briley M: Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability. Int Clin Psychopharmacol 1997; 12: 99-108.
41. Matsubara R, Onodera I, Ito K, Okada F, Asano Y: Clinical evaluation of milnacipran hydrochloride (TN-912) on depression and depressive states. -Phase III clinical trial with imipramine hydrochloride as a control drug. -J Clin Therap Med 1995; 11: 819-842. (in Japanese with English abstract)
42. Endo S, Miura S, Murasaki M, Miyasaka M, Yamauchi T, Asai M, Ushijima S, Kamijima K, Hasegawa K, Kariya T, Kudo Y, Nakajima T, Nishimura T, Nakane Y, Ogura T: Clinical evaluation of Milnacipran hydrochloride, a new antidepressant for depression and depressive state. -Phase III clinical trial with mianserin hydrochloride as a control drug. -Clin Eval 1995; 23: 39-64. (in Japanese with English abstract)
43. Lopez-Ibor J, Guelfi JD, Pletan Y, Tournoux A, Prost JF: Milnacipran and selective serotonin reuptake inhibitors in major depression. Int Clin Psychopharmacol 1996; 11 Suppl 4: 41-46.
44. Puozzo C, Leonard BE: Pharmacokinetics of milnacipran in comparison with other antidepressants. Int Clin Psychopharmacol 1996; 11 Suppl 4: 15-27.
45. Moller HJ: Are all antidepressants the same?: J Clin Psychiatry 2000; 61 Suppl 6: 24-28.
46. Mittenberg W, DiGiulio DV, Perrin S: Symptoms following mild head injury: expectation as aetiology: J Neurol Neurosurg Psychiatry 1992; 55: 200-204, 1992.
47. Starkstein SE, Fedoroff JP, Price TR: Apathy following cerebrovascular lesions. Stroke 1993; 24: 1625-1630.